WHAT WE DO
BioAxone is making great strides in developing products that will make a difference and change the world.
Research driven medical solutions is what we strive for. Our goal is changing lives in a healthier way.
About Us
Learn more about our company.
Over A Decade Serving The Medical Community
In the early part of 2000, Bioaxone was formed to commercialize the use of Rho GTPase inhibition and determine its use in central nervous system nerve regeneration after injury. With licensed technology from the University of Montreal and investments from four major firms in Quebec, Bioaxone began its mission to create viable spinal cord injury treatments. We have always met or exceed our targets.
Innovation is what we do.
Research-driven medical solutions
Sustainability is Key